AGP Picks
View all

Mongolia Business Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Business Digest.

Press releases published on September 29, 2026

Apriem Advisors Earns Three National and Regional Recognitions in 2026
Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors
PyroGenesis Completes Acquisition of 50% Ownership Interest in HPQ Silica Polvere Inc., Rights-Holder of the Fumed Silica Reactor Technology
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
Scintil Photonics Appoints Alexandru Romanescu as Vice President of Process Engineering
KPMG Study Finds Falco’s Horne 5 Project Is Projected to Contribute $8.8 Billion to Québec GDP
Une étude de KPMG prévoit que le projet Horne 5 de Falco devrait contribuer à hauteur de 8,8 milliards de dollars au PIB du Québec
My Divorce Solution Publishes Divorce Clarity Guide
Amplify ETFs Declares September Income Distributions for its Income ETFs
GoldHaven Highlights Multi-Target Drill Opportunity Across Permitted Magno Project
Flagship Communities Real Estate Investment Trust Bolsters Presence in Kentucky with Acquisition of 125-Lot Manufactured Housing Community
Xanadu and Bluefors Partner to Redefine Cryogenic Infrastructure for Utility-Scale Quantum Computing
Stallion Uranium Recommences Phase II Drilling at Moonlite Project
Alpha Compute Update on Operating Oil and Gas Assets Due Diligence in Pennsylvania, Securing 300+ Acres Across the Marcellus and Utica Shales
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
Luckin Coffee Announces Appointment of New Director
GDEV announces preliminary results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for…

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Mongolia Business Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.